Jounce Therapeutics JNCE

$ 1.88 0.0%

Annual report 2022
added 04-28-2023

Jounce Therapeutics EV/EBITDA Ratio 2011-2024 | JNCE

Annual EV/EBITDA Ratio Jounce Therapeutics

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-3.77	-5.8	2.75	-2.96	-50.7	-37.4	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
2.75	-50.7	-16.3